by EmpathiCSubstanceS | Apr 25, 2021 | Psychedelic Medicine
While the 2020 US election has turned into a nail-biter with a deeply partisan divide splitting the country with razor-thin margins, a broad array of ballot measures relating to drug reform have turned out to be some of the only things Americans seem to agree on. A...
by EmpathiCSubstanceS | Apr 25, 2021 | Cannabis Marijuana
Robust new research, published in the journal Translational Psychiatry, is reporting on several years of animal studies showing how a psychedelic drug called dimethyltryptamine (DMT) can promote brain plasticity and induce the formation of new neurons. The research...
by EmpathiCSubstanceS | Apr 25, 2021 | Addiction, Cannabis Marijuana
A first-of-its-kind exploratory study, led by researchers from Yale School of Medicine, has found a single dose of the psychedelic psilocybin can reduce migraine frequency by 50 percent for a least two weeks. The preliminary trial was small, with follow-up work...
by EmpathiCSubstanceS | Apr 25, 2021 | Cannabis Marijuana
A novel study investigating the effects of cannabis on driving in a real-world context has found cannabidiol (CBD) alone does not impair driving ability. The landmark finding promises to be invaluable in guiding road safety regulations as cannabis laws shift across...
by EmpathiCSubstanceS | Apr 25, 2021 | MDMA Sassafras Molly
In the late 1970s and early 1980s MDMA was often utilized to help facilitate positive results in couples counseling. A few dozen pioneering psychotherapists in the United States explored the drug’s therapeutic uses until the US government declared MDMA a Schedule 1...
